Palmitoyl Pentapeptide-4 (Matrixyl)
Collagen-boosting signal peptide clinically proven to reduce wrinkles and fine lines in photoaged skin.
Written by Michael Carroll — Owner, Director of Research · Reviewed by the Peptide Initiative Research Team · Editorial standards
Suggested dose
0.012 % – 3 ppm
Compound profile
Scientific & efficacy data
Cosmetic
Peptide profile
Limited human trials
Palmitoyl Pentapeptide-4 (Matrixyl)
3 ppm (0.0003%) active peptide · Once daily
Molecular formula
C39H75N7O10
- Mol. weight
- 802.1 Da
- CAS number
- 214047-00-4
- PubChem
- 9897237
- Developed · 2004
- Sederma research team
Sederma S.A. (part of Croda International)
Amino acid sequence
Pal-Lys-Thr-Thr-Lys-Ser (Pal-KTTKS), a palmitoylated fragment of type I procollagen C-terminal propeptideAnti-Wrinkle
Clinically demonstrated wrinkle and fine line reduction in a 12-week double-blind placebo-controlled trial at just 3 ppm concentration.
Collagen Production
Potent stimulation of collagen types I, III, and IV along with fibronectin and glycosaminoglycans through TGF-β pathway activation.
Skin Rejuvenation
Comprehensive ECM support including elastin and hyaluronic acid enhancement for improved skin density, firmness, and hydration.
Dosing
How much do I take?
0.012 % – 3 ppm · twice daily
0.012 % – 3 ppm
Twice daily
Covers all 2 documented dose levels · timing · dose-adjustment guidance.
Suitability
Is this right for me?
Best for individuals seeking non-invasive anti-wrinkle treatment & those with photoaged skin showing fine lines and loss of firmness
Best for
Individuals seeking non-invasive anti-wrinkle treatment
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on individuals seeking non-invasive anti-wrinkle treatment. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Those with photoaged skin showing fine lines and loss of firmness
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on those with photoaged skin showing fine lines and loss of firmness. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
People looking to boost collagen production through topical skincare
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on people looking to boost collagen production through topical skincare. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Sensitive skin types seeking well-tolerated anti-aging actives
Palmitoyl Pentapeptide-4 (Matrixyl) is particularly well-suited for individuals focused on sensitive skin types seeking well-tolerated anti-aging actives. Research and clinical experience suggest meaningful benefits in this area when used as part of a comprehensive treatment approach.
Consider alternatives if
Do not use if
Use with caution if
Not sure?
Compare Palmitoyl Pentapeptide-4 (Matrixyl) with similar peptides to find the best fit for your goals.
Administration
How do I use it?
Topical
Route
Palmitoyl Pentapeptide-4 (Matrixyl) is administered Topical—no injection required
Best sites
Covers reconstitution · step-by-step technique · storage · a sample daily schedule.
Safety
Is it safe?
4 common side effects · 2 serious
Palmitoyl pentapeptide-4 (Matrixyl) demonstrates excellent dermatological safety with GRAS/safe-for-cosmetic status; extensively used in anti-aging skincare for 20+ years with no serious adverse events.
Skin irritation potential is minimal at recommended 2-3% concentrations (irritation index <0.5). No systemic absorption via intact skin; confined to epidermis/dermis per Franz diffusion cell studies. Stability in formulations verified through HPLC analysis.
Clinical dermatology studies using non-invasive biophysical measurements document collagen production increases (ultrasound elastography and mechanical testing show 15-35% firmness improvements).
Procollagen type I expression quantified via real-time PCR shows 2-3 fold increases after 12 weeks application. Collagen remodeling confirmed through dermoscopy and skin biopsy immunostaining showing enhanced type I/type III collagen architecture.
Common side effects · experienced by some users
Mild Tingling
Slight tingling sensation upon initial application, particularly in individuals with sensitive skin. Typically resolves within minutes.
Management: Normal response. If persistent, reduce application frequency to once daily.
Transient Redness
Temporary mild redness at application site in sensitive individuals, usually self-resolving within 30 minutes.
Management: Apply to a test area first. If redness persists, discontinue and consult dermatologist.
Dryness with Exfoliants
Mild skin dryness when used concurrently with strong exfoliating acids (AHA, BHA).
Management: Space application of peptide products and exfoliants. Use a hydrating moisturizer over the peptide serum.
Mild Irritation
Minor irritation possible when layered with multiple active ingredients simultaneously.
Management: Simplify routine. Alternate active ingredients on different days if irritation occurs.
Less common
These typically resolve with continued use or dose adjustment.
Stop and seek help if
- Severe or worsening side effects that don't improve with dose adjustment or supportive care
- Signs of an allergic reaction—rash, hives, swelling, or difficulty breathing
- Your healthcare provider recommends discontinuation based on your clinical response
- Development of any new medical condition that may be contraindicated with Palmitoyl Pentapeptide-4 (Matrixyl)
- Pregnancy or planning to become pregnant (unless specifically approved for use during pregnancy)
- Abnormal lab results or clinical markers that suggest adverse effects
Palmitoyl Pentapeptide-4 (Matrixyl) should only be started, adjusted, or discontinued under medical supervision. This information is for educational purposes only and does not replace professional medical advice. Never stop a prescribed treatment without consulting your healthcare provider first, as abrupt discontinuation may have consequences.
With other peptides
- Safe:Vitamin C (Ascorbic Acid) — May be used together under medical guidance.
- Safe:Hyaluronic Acid — May be used together under medical guidance.
- Safe:Retinol — May be used together under medical guidance.
With medications
- Caution:Strong Acids at Low pH (<3) — Use with caution—discuss with your healthcare provider.
- Caution:High-Concentration Copper Peptides — Use with caution—discuss with your healthcare provider.
- Caution:Strong Oxidizing Agents (Benzoyl Peroxide) — Use with caution—discuss with your healthcare provider.
With supplements
- Safe:Multivitamins — Generally safe to take alongside Palmitoyl Pentapeptide-4 (Matrixyl). Space doses apart if taking oral formulations to ensure optimal absorption.
- Safe:Electrolyte supplements — Helpful if experiencing any GI side effects that could lead to dehydration. Safe to combine.
Effectiveness
How do I know it's working?
Limited human trials · first signs weeks 1-4
Evidence level
Limited human trials
Regulatory status
Research compound
Onset of effects
Moderate
(1-2 weeks)
How it works
Palmitoyl-pentapeptide-4 is a longer signal peptide with a fatty acid attachment that stimulates collagen production in your skin.
It mimics the growth factors your skin uses to rebuild itself, telling fibroblasts to make more collagen and elastin. With consistent use, this leads to firmer, more elastic skin with visible reduction in wrinkles and improved texture.
The deeper mechanism
Palmitoyl-pentapeptide-4 (Matrixyl) is a five-amino acid peptide conjugated to palmitic acid that acts as a signal peptide mimicking growth factor signaling for collagen synthesis.
The lipidated structure improves skin penetration and cellular uptake, allowing the pentapeptide to interact with fibroblast receptors (including potential IGF-1 and TGF-β pathway components) that increase type I collagen mRNA expression and protein synthesis.
Palmitoyl-pentapeptide-4 upregulates fibroblast activity through growth factor receptor mimicry, increases dermal matrix deposition, and stimulates tissue remodeling through controlled MMP activation.
Clinical studies document measurable improvements in skin thickness, elasticity, and wrinkle depth with 4-12 weeks of consistent topical application at 5-10% concentrations.
What to expect
Weeks 1-4
What you might notice
- Skin begins adapting to the peptide
- Fibroblast stimulation initiated at the cellular level
- Improved skin hydration and texture may be noticed
- No visible wrinkle changes yet
What's normal
- Full integration of Palmitoyl Pentapeptide-4 (Matrixyl) into physiological systems is established
- Long-term Palmitoyl Pentapeptide-4 (Matrixyl) response remains personalized to your physiology
- Palmitoyl Pentapeptide-4 (Matrixyl) tolerance is well-maintained with consistent dosing
What's next
- Maintain your established Palmitoyl Pentapeptide-4 (Matrixyl) protocol for sustained benefits
- Continue periodic monitoring to confirm Palmitoyl Pentapeptide-4 (Matrixyl) efficacy
- Review comprehensive Palmitoyl Pentapeptide-4 (Matrixyl) response with your provider
Weeks 4-12
What you might notice
- Collagen synthesis ramps up
- Early improvements in fine lines, skin firmness, and overall radiance become apparent
- Clinical trial data shows measurable wrinkle depth reduction beginning in this period
What's normal
- Palmitoyl Pentapeptide-4 (Matrixyl) is now achieving steady-state pharmacokinetics
- Measurable changes aligned with Palmitoyl Pentapeptide-4 (Matrixyl)'s mechanism may appear
- Initial adjustment effects typically resolve by this point
What's next
- Maintain Palmitoyl Pentapeptide-4 (Matrixyl) dosing exactly as established
- Track progress toward intended outcomes in detail
- Review lab work or biomarker changes with your healthcare team
Weeks 12-24+
What you might notice
- Significant reduction in fine lines and wrinkles
- Improved skin density and elasticity
- Continued use maintains and extends benefits
- ECM remodeling reaches steady-state improvement
What's normal
- Full therapeutic effects of Palmitoyl Pentapeptide-4 (Matrixyl) are well-characterized at this point
- Maintenance of Palmitoyl Pentapeptide-4 (Matrixyl)'s therapeutic effects is typical
- Tolerance patterns with Palmitoyl Pentapeptide-4 (Matrixyl) are generally stable over months
What's next
- Comprehensive assessment of Palmitoyl Pentapeptide-4 (Matrixyl) efficacy should be conducted
- Discuss long-term continuation, cycling, or protocol modifications
- Continue regular monitoring of relevant biomarkers or symptoms
Signs it's working
Treatment Response
- Improvement in the primary symptoms or condition being treated
- Positive changes in relevant lab values or clinical markers
- Consistent, stable response to Palmitoyl Pentapeptide-4 (Matrixyl) over time
- Reduction in symptom frequency or severity
General Well-being
- Improved energy levels and daily functioning
- Better quality of life related to the treated condition
- Manageable or absent side effects indicating good tolerance
- Positive feedback from healthcare provider during check-ups
Not seeing results? Common reasons
- Not at therapeutic dose yet—initial doses are for building tolerance, not maximum effect
- Insufficient time at target dose—most compounds need several weeks to show full benefits
- Inconsistent dosing schedule—regular, consistent use is crucial for optimal results
- Individual variation in response—genetics, metabolism, and other factors affect outcomes
- Underlying conditions or medications interfering with absorption or effectiveness
- Improper storage leading to degraded product—always verify proper storage conditions
Key research
Questions
Frequently asked
What is the difference between Matrixyl and Matrixyl 3000?
Matrixyl (Palmitoyl Pentapeptide-4) is the original single-peptide product with the sequence Pal-KTTKS. Matrixyl 3000 is a later formulation combining two different peptides — Palmitoyl Tripeptide-1 and Palmitoyl Tetrapeptide-7 — for synergistic anti-aging effects through complementary mechanisms. Both are developed by Sederma.
How does Matrixyl compare to retinol for anti-aging?
Matrixyl and retinol work through different mechanisms. Matrixyl directly signals fibroblasts to produce collagen via the TGF-β pathway, while retinol modulates gene expression through retinoic acid receptors. Matrixyl is generally better tolerated with fewer side effects, making it suitable for sensitive skin. Many dermatologists recommend using both in complementary routines for maximum anti-aging benefit.
Can Matrixyl be used around the eyes?
Yes. Matrixyl is well-tolerated in the delicate periorbital area and has been specifically tested for crow's feet and fine lines around the eyes. Its excellent safety profile and non-irritating nature make it suitable for eye-area formulations.
How long does it take to see results from Matrixyl?
Clinical studies show statistically significant wrinkle reduction after 12 weeks of consistent twice-daily application at concentrations as low as 3 ppm. Some users report improvements in skin texture and hydration within 4-8 weeks, but measurable anti-wrinkle effects require at least 12 weeks of regular use.
Is Matrixyl safe during pregnancy?
Palmitoyl Pentapeptide-4 is rapidly degraded by skin enzymes with minimal systemic absorption, making it generally considered safe for topical use. However, as with most cosmetic actives, limited pregnancy-specific safety data exists. Consult with a healthcare provider before introducing new skincare actives during pregnancy.
Further reading
History & related research
History · since 2000
The wrinkle fighter that teaches old skin to act young again
Matrixyl is a tiny messenger that talks to your skin's deep layers. It tells cells to make more collagen, the stuff that keeps skin firm and smooth.
Read the full history of Palmitoyl Pentapeptide-4 (Matrixyl)Ready for the protocol?
Every dosing tier, administration route, timing note, and dose-adjustment rule for Palmitoyl Pentapeptide-4 (Matrixyl), on one page.